OncoPrecision

📍 New York, United States🗓 Founded 2020👥 34 employees💰 Last funded Jun 2022
Biotechnology Research🌐 oncoprecision.bio
Website LinkedIn
Were developing technologies to replicate cancer patients disease ex-vivo to rapidly and accurately test a broad range of treatments simultaneously to help oncologists provide the most suitable treatment for each patient and pharmaceutical companies develop transformational therapies.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in OncoPrecision?
OncoPrecision has 2 investors on record on gritt.io, including 2 early-stage backers.
When did OncoPrecision last raise funding?
The most recent investment in OncoPrecision recorded on gritt.io was in June 2022.
When was OncoPrecision founded?
OncoPrecision was founded in 2020.
What industry is OncoPrecision in?
OncoPrecision operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is OncoPrecision based?
OncoPrecision is headquartered in New York, United States.